These three buy-rated cannabis stocks could be set to benefit as both leading presidential candidates show growing support for legalization.
OGI earnings call for the period ending June 30, 2024.
OGI earnings call for the period ending March 31, 2024.
While they do carry higher-than-average risk, these microcaps also offer major upside potential for investors seeking startup-sized returns.
OGI earnings call for the period ending December 31, 2023.
OGI earnings call for the period ending September 30, 2023.
There's some potentially very good news coming soon from the halls of Congress.
Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential,...
OGI earnings call for the period ending June 30, 2023.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023...